COLON-MD: Colon Cancer Longitudinal Study
Recruiting · NCT04751448 · Observational (researchers observe without assigning treatment) · Lead sponsor: Baylor Research Institute
View the official record on ClinicalTrials.gov →What this trial is about
The goal of this proposal is to identify how the composition of the gut microbiome and diet interact to impact chemotherapy-induced diarrhea incidence and severity.
Who can take part
Age range
18 Years to 79 Years
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)
Inclusion criteria
- Colon cancer diagnosis
- Age \>18 and \< or equal to 79.
- Ability to perform informed consent
- FOLFOX treatment expected
Exclusion criteria
- Not Pregnant
- Does not have Lynch syndrome or FAP diagnosis.
- Inability to perform inform consent
- inability to comply with follow up program
- history of prior colon cancer diagnosis
- previous treatment with antibiotics in the last month.
- previous bowel resection.
Where it is running
1 location listed across 1 US state.
- Baylor Research Institute - Temple, Texas, United States